Pharmafile.com’s weekly COVID-19 news round-up
April 7, 2021Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news
The past week has seen plenty of COVID-19 vaccine news; AstraZeneca has halted the paediatric trial of their jab amid …
UK begins rollout of Moderna COVID-19 vaccine
April 7, 2021Research and Development COVID-19, COVID-19 vaccine, Moderna, Moderna vaccine, pharma, pharma news
The first Moderna COVID-19 vaccine in the UK has today been administered, beginning the rollout of the country’s third vaccine …
Novartis and Artios Pharma to collaborate on DDR cancer therapies
April 7, 2021Research and Development Novartis, RLT, oncology
Novartis and Artios Pharma have announced a global research collaboration to discover and validate next generation DNA damage response (DDR) …
AstraZeneca halt paediatric trial of COVID-19 vaccine amid blood clot probe
April 7, 2021Research and Development AstraZeneca, COVID-19, Vaccine
AstraZeneca has halted the trial of its COVID-19 vaccine on children aged between 6 and 17, while regulators investigate a …
NICE recommends CBT, acupuncture, and anti-depressants for chronic pain
April 7, 2021Research and Development NICE, antidepressant, chronic pain
A new NICE guideline on the assessment and management of chronic primary pain does not recommend the prescription of painkillers, …
Valneva’s inactivated COVID-19 vaccine candidate advances to Phase III trial
April 6, 2021Manufacturing and Production COVID-19, COVID-19 vaccine, Valneva, Valneva vaccine, inactivated vaccine
Specialty vaccine company Valneva’s inactivated COVID-19 jab has shown positive results in a Phase I/II trial, with a seroconversion rate …
Janssen agrees $780 million deal for authorisation of Cidara flu treatment
April 6, 2021Manufacturing and Production Janssen, cidara, influenza
Janssen has struck a deal worth up to $780 million with Cidara Therapeutics for exclusive worldwide rights to Cidara’s CD388 …
Pfizer vaccine 91.3% effective after six months, Phase III study shows
April 6, 2021Manufacturing and Production BioNTech, COVID-19, COVID-19 vaccine, Pfizer, Pfizer vaccine, pfizer-biontech vaccine
Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, …
Alnylam publish successful results from Phase III study of ultra-rare disease
April 6, 2021Manufacturing and Production
Alnylam Pharmaceuticals, a RNAi therapeutics company, have published successful results from their Phase III study of lumasiran, the first ever …
FDA approves first new ADHD drug in a decade
April 6, 2021Manufacturing and Production ADHD, FDA, paediatric
The FDA have approved the first new drug for the treatment of attention deficit hyperactivity disorder (ADHD) in over a …
Pharmafile.com’s top 10 news stories of the week
April 2, 2021COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma news
In the last week, a number of new COVID-19 developments have emerged; Novavax has delayed 100 million vaccines to the …
EC grants marketing authorisation to Angelini Pharma’s epilepsy treatment
April 1, 2021Angelini Pharma have announced that the European Commission (EC) have granted marketing authorisation for Ontozry (cenobamate) for the treatment of …
New Sanofi Sarclisa treatment for multiple myeloma approved by FDA
April 1, 2021FDA, FDA Approval, Sanofi, Sarclisa, multiple myeloma
Sanofi’s Sarclisa drug has been approved by the FDA in combination with carfilzomib and dexamethasone (Kd) for the treatment of …
Newron announce successful results from schizophrenia study
April 1, 2021schizophrenia
Newron, a biopharmaceutical company focused on novel therapies, have announced the initial results from two short-term exploratory studies assessing the …
BD’s rapid COVID-19 test granted Emergency Use Authorization by FDA
April 1, 2021BD, COVID-19, COVID-19 testing, EUA, FDA
The FDA has granted Emergency Use Authorization (EUA) for Becton, Dickinson and Company’s (BD) rapid antigen test to be used …
NICE recommends Kineret for Still’s disease treatment
April 1, 2021NICE
Sobi has today announced a NICE recommendation of Kineret (anakinra) as a first-line biologic therapeutic option for still’s disease, including …
The Truth Behind the £1.8 Million Drug
March 31, 2021Manufacturing and Production FDA, NHS, NICE
As NICE approves the most expensive drug ever for use by the NHS, Jack Goddard takes a look at drug …
Real-world evidence and clinical research diversity
March 31, 2021Research and Development rwe
Clinical trials are immensely valuable in establishing the safety and effectiveness of a drug in carefully selected participants, but what …
Pharmafile.com’s weekly COVID-19 news round-up
March 31, 2021Research and Development COVID-19, covid 19 news, covid-19 news, covid-19 roundup
The past week has seen plenty of positive COVID-19 news; Starpharma are to start selling their COVID-fighting nose spray in …
Amryt submits NDA to the FDA for Oleogel-S10
March 31, 2021Research and Development FDA
Amryt has today announced the rolling submission of a New Drug Application (NDA) to the FDA for Olegel-S10, potential treatment …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
